CORDIS
EU research results

CORDIS

English EN
SensoGenic: empower food allergy sufferers and their families with the freedom to enjoy eating safely everywhere & anytime

SensoGenic: empower food allergy sufferers and their families with the freedom to enjoy eating safely everywhere & anytime

Objective

SensoGenic Ltd. is a science and technology company based in Israel, that is developing food allergens biosensor which is
a portable, handheld, a digital diagnostic analyser for consumers. https://www.sensogenic.com Today, there isn't any
consumer solution in the market that address food allergens detection. The solution for food manufactures is very long and
expensive laboratory tests. SensoGenic will focus on consumer product that detects milk and eggs simultaneously in
relevant food and concentrations. After successfully validating the POC of SensoGenic, based on company own research
and experiments as well as supportive academic articles, the team can confirm the capability of its breakthrough IP as
unique approach for allergens proteins detection. By pursuing the present feasibility study, the management team aims to
improve its understanding of international market conditions and the associated risks that need to be considered as the
company develops a deeper business plan for rolling out, and scaling up SensoGenic as a marketable innovative solution.
SME Instrument Phase-1 and Phase-2 will be extremely beneficial in helping the company to accelerate development and
market penetration of the solution in target segments, boosting the company’s growth to 100 employees and €26,000,000
revenues by 2025.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

SENSOGENIC LTD

Address

Chaim Weizmann 28
7628210 Rehovot

Israel

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 50 000

Project information

Grant agreement ID: 867865

Status

Ongoing project

  • Start date

    1 March 2019

  • End date

    31 August 2019

Funded under:

H2020-EU.3.

H2020-EU.2.3.

H2020-EU.2.1.

  • Overall budget:

    € 71 429

  • EU contribution

    € 50 000

Coordinated by:

SENSOGENIC LTD

Israel